Xenogeneic extracellular matrix as a scaffold for tissue reconstruction

被引:554
作者
Badylak, SF [1 ]
机构
[1] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA
关键词
extracellular matrix; tissue engineering; small intestinal submucosa (SlS); urinary bladder matrix (UBM); xenogeneic scaffold; bioscaffold; regenerative medicine; immune response;
D O I
10.1016/j.trim.2003.12.016
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Bioscaffolds derived from xenogeneic extracellular matrix (ECM) have been used in numerous tissue engineering applications. The safety and efficacy of such scaffolds when used for the repair and reconstruction of numerous body tissues including musculoskeletal, cardiovascular, urogenital and integumentary structures has been shown in both preclinical animal studies and in human clinical studies. More than 200 000 human patients have been implanted with xenogeneic ECM scaffolds. These ECM scaffolds are typically prepared from porcine organs such as small intestine or urinary bladder, which are subjected to decellularization and terminal sterilization without significant loss of the biologic effects of the ECM. The composition of these bioscaffolds includes the structural and functional proteins that are part of native mammalian extracellular matrix. The three-dimensional organization of these molecules distinguishes ECM scaffolds from synthetic scaffold materials and is associated with constructive tissue remodeling instead of scar tissue. The biologic response to these xenogeneic bioscaffolds, including the immune response, is discussed herein. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:367 / 377
页数:11
相关论文
共 125 条
  • [81] Fibronectin and integrins in cell adhesion, signaling, and morphogenesis
    Miyamoto, S
    Katz, BZ
    Lafrenie, RM
    Yamada, KM
    [J]. MORPHOGENESIS: CELLULAR INTERACTIONS, 1998, 857 : 119 - 129
  • [82] Moore MA, 1997, J HEART VALVE DIS, V6, P307
  • [83] MUSAHL V, IN PRESS J ORTHOP RE
  • [84] Morphologic and mechanical characteristics of engineered bovine arteries
    Niklason, LE
    Abbott, W
    Gao, JM
    Klagges, B
    Hirschi, KK
    Ulubayram, K
    Conroy, N
    Jones, R
    [J]. JOURNAL OF VASCULAR SURGERY, 2001, 33 (03) : 628 - 638
  • [85] Niklason LE, 1997, TRANSPL IMMUNOL, V5, P303
  • [86] NIKLASON LE, 2000, ATHEROSCLEROSIS JUL, V151, P93
  • [87] Percutaneous bioprosthetic venous valve:: A long-term study in sheep
    Pavcnik, D
    Uchida, BT
    Timmermans, HA
    Corless, CL
    O'Hara, A
    Toyota, N
    Moneta, GL
    Keller, FS
    Rösch, J
    [J]. JOURNAL OF VASCULAR SURGERY, 2002, 35 (03) : 598 - 602
  • [88] Square stent:: A new self-expandable endoluminal device and its applications
    Pavcnik, D
    Uchida, B
    Timmermans, H
    Keller, FS
    Rösch, J
    [J]. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2001, 24 (04) : 207 - 217
  • [89] Formation of a SIS-cartilage composite graft in vitro and its use in the repair of articular cartilage defects
    Peel, SAF
    Chen, H
    Renlund, R
    Badylak, SF
    Kandel, RA
    [J]. TISSUE ENGINEERING, 1998, 4 (02): : 143 - 155
  • [90] Are Th2 helper T lymphocytes beneficial, deleterious, or irrelevant in promoting allograft survival?
    Piccotti, JR
    Chan, SY
    VanBuskirk, AM
    Eichwald, EJ
    Bishop, DK
    [J]. TRANSPLANTATION, 1997, 63 (05) : 619 - 624